Drug Study

Name of Patient: Attending Physician:

Dosage, Route,
Name of Drug Frequency and Mechanism of Action Indication Adverse Reactions Special Precautions Nursing Responsibilities
Timing

Generic: Dosage: Increases insulin concurrent use with Hyperglycemic rebound; Use cautiously in: Administer with a meal.
metformin sensitivity by decreasing insulin in type 2 Lactic acidosis ● renal impairment, Monitor blood glucose level closely
500 mg/tab 1 tab glucose production and diabetes mellitus myocardial infarction, Monitor kidney and liver function
absorption in liver and chronic alcohol use tests, particularly in elderly
Brand: intestines and enhancing ● elderly or patients.
Riva-Metformin Route: glucose uptake and debilitated patients Periodically monitor glucose and
Po utilization glycosylated hemoglobin levels to
evaluate drug efficacy.
Teach patient about diabetes and
importance of proper diet,
Frequency: exercise, weight control, and
Od blood glucose monitoring.
Inform patient that drug may
Classification Contraindications Side Effects cause diarrhea, nausea,and upset
stomach.
Functional: Timing: Hypersensitivity to drug Diarrhea ,nausea ,
Hypoglycemic 8 vomiting ,abdominal
agent bloating unpleasant
Chemical: metallic taste
biguanide
 Drug Study
Name of Patient: Attending Physician:
Age: Ward/Bed Number: Impression/ Diagnosis:

Dosage, Route,
Name of Drug Frequency and Mechanism of Action Indication Adverse Reactions Special Precautions Nursing Responsibilities
Timing

Generic: Dosage: Linagliptin is an inhibitor Glycemic control in Hypersensitivity reaction; Use cautiously in:  Assess for drug allergies.
Linagliptin + of the enzyme DPP-4 patients with Type 2 pancreatitis; ● renal impairment,  Assess for recent history of
Metformin 2.5/500 mg/tab, (Dipeptidyl peptidase 4) DM nasopharyngitis myocardial infarction, alcohol intake.
1 tab an enzyme which is chronic alcohol use  Assess for signs and
involved in the ● elderly or symptoms of
inactivation of the incretin debilitated patients hypoglycemia.
Brand: Route: hormones GLP-1 and GIP  Monitor for changes in
Trajenta Duo Po (glucagon-like peptide-1, pancreatic enzyme levels.
glucose-dependent  Encourage small frequent
insulinotropic meals for anorexia.
polypeptide). These  Promote fluid intake for
Frequency: hormones are rapidly cough. Avoid cold water.
Od degraded by the enzyme  Encourage bed rest for
Classification DPP-4. Both incretin Contraindications Side Effects nausea. Promote client
hormones are involved in safety.
Functional: the physiological Hypersensitivity to drug Cough; anorexia; nausea,  Monitor I & O for vomiting
Antihyperglycemic Timing: regulation of glucose and its component vomiting; diarrhea and diarrhea. Replace fluid
agent 8 homeostasis. Linagliptin loss
glucose-dependently
Chemical: increases insulin secretion
Purine and and lowers glucagon
quinazoline secretion thus resulting in
derivative an overall improvement in
the glucose
homoeostasis.